调整潜在的混杂因素后，服用罗格列酮的病人比服用匹格列酮的病人的死亡率高15%，心衰风险高13%。

Adjusting for potential confounding factors, individuals on rosiglitazone had 15% higher rate of death and 13% higher risk of heart failure.

youdao

调整潜在的混杂因素后，服用罗格列酮的病人比服用匹格列酮的病人的死亡率高15%，心衰风险高13%。

Adjusting for potential confounding factors, individuals on rosiglitazone had 15% higher rate of death and 13% higher risk of heart failure.

youdao